Previous Close | 0.2100 |
Open | 0.2100 |
Bid | 0.1510 x 0 |
Ask | 0.2399 x 0 |
Day's Range | 0.2100 - 0.2100 |
52 Week Range | 0.0100 - 1.5500 |
Volume | |
Avg. Volume | 6,481 |
Market Cap | 16.85M |
Beta (5Y Monthly) | 1.45 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.9400 |
Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.83 |
Growth and Restructuring Initiatives Lead to Quarter-over-Quarter Growth Across all Key Financial Metrics in Q2 Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the second quarter ended June 30, 2024. “We made solid progress on our growth and optimization initia
DENVER, July 30, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Tuesday, August 13, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2024. The Company’s results will be reported in a press release prior to the call. The Schwazze management team will host the conference call, followed by a question-and-answ